Molecular biology of chronic myelogenous leukemia
Tanzer, J.
Nouvelle Revue Francaise d'Hematologie 33(2): 197-200
1991
ISSN/ISBN: 0029-4810 PMID: 1766852 Document Number: 370773
Document emailed within 1 workday
Related Documents
Cea, M.; Cagnetta, A.; Garuti, A.; Cirmena, G.; Rocco, I.; Moran, E.; Grillo, V.; Ballestrero, A.; Patrone, F.; Nencioni, A. 2009: Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more Journal of BUON: Official Journal of the Balkan Union of Oncology 14(4): 565-573Reed, J.C. 1998: Molecular biology of chronic lymphocytic leukemia Seminars in Oncology 25(1): 11-18
Sinkovics, J.; Horváth, J. 2001: Molecular biology investigations in chronic lymphocytic leukemia Orvosi Hetilap 142(42): 2338-2339
Cervantes, F. 1993: Molecular biology studies in chronic myeloid leukemia Medicina Clinica 101(14): 538-540
Sacha, T.; Dulak, J.; Skotnicki, A.B.; Dembińska-Kiec, A. 1999: Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification Przeglad lekarski 56 Suppl. 1: 57-61
Michalová, K.; Zemanová, Z.; Haskovec, C.; Rypácková, B.; Brdicka, R. 1992: Use of cytogenetic and molecular biology in the detection of chronic myeloid leukemia Casopis Lekaru Ceskych 131(24-25): 729-732
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J. 1994: Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample Human Cell 7(3): 167-171
Guilhot, F. 1994: The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S39-S46
Tauchi, T.; Ohyashiki, K. 2007: New horizon of chronic myelogenous leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 1): 75-79
Kapsali, E.; Tsiara, S.; Christou, L.; Panteli, A.; Bourantas, K.L. 2000: Two siblings with chronic myelogenous leukemia Journal of Experimental and Clinical Cancer Research: Cr 19(4): 541-543
Bernstein, R. 1988: Cytogenetics of chronic myelogenous leukemia Seminars in Hematology 25(1): 20-34
De Klein, A.; Bartram, C.R.; Hagemeijer, A.; Heisterkamp, N.; Stam, K.; Groffen, J.; Grosveld, G. 1987: The c-abl oncogene in chronic myelogenous leukemia Haematologica 72(6 Suppl): 19-22
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Cortes, J. 2012: Bosutinib in the treatment of chronic myelogenous leukemia Clinical Advances in Hematology and Oncology: H&o 10(11): 736-737